Streetbeat News

Regulatory

AMAM

Ambrx is set to present preliminary safety, efficacy, and pharmacokinetics data for ARX517 at ESMO 2023. The data is from the first-in-human trials of the drug.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 12:31 pm

MRUS

Merus has announced that two clinical abstracts on Zenocutuzumab in NRG1-fusion non-small cell lung cancer and pancreatic cancer have been selected for presentation at the ESMO Congress 2023.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 12:08 pm

KDNY

Chinook Therapeutics has announced the enrollment of the first patient with IgA Nephropathy in the BEYOND Phase 3 trial. The trial is aimed at evaluating the safety and efficacy of Zigakibart (BION-1301-1301).

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 12:03 pm

MSFT

Microsoft Corp (NASDAQ:MSFT) is under scrutiny over a security breach that allowed Chinese hackers to spy on top Biden administration officials. The breach is believed to be worse than initially thought, compromising the unclassified Microsoft email inboxes of senior State Department officials, Commerce Secretary Gina Raimondo, and others. Senator Ron Wyden has requested three separate federal probes into Microsoft's alleged negligent cybersecurity practices. The hack has affected more than two dozen organizations globally, with fewer than ten organizations compromised in the U.S.

Portfolio Pulse from Anusuya Lahiri

July 28, 2023 | 11:48 am

SOYB

SPY

VGK

WEAT

The Chief of Staff for the Ukrainian President has stated that Russia is threatening civilian vessels in the Black Sea, and has called for international condemnation. This could potentially impact global trade and commodities.

Portfolio Pulse from Charles Gross

July 28, 2023 | 11:42 am

ABEO

Abeona Therapeutics has submitted the briefing package to the FDA for its pre-biologics license application meeting in August 2023. The application is for EB-101, an engineered cell therapy for Recessive Dystrophic Epidermolysis Bullosa.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 11:38 am

GE

The FDA has announced that GE Healthcare is recalling its Trusignal Spo2 Sensors due to issues that may reduce defibrillation energy and expose patients to unintended voltage.

Portfolio Pulse from Charles Gross

July 28, 2023 | 11:27 am

IMMP

MRK

Immutep Limited has announced the first patient has been enrolled and safely dosed in EFTISARC-NEO, the Phase II trial of eftilagimod alpha, in combination with radiotherapy and the anti-PD-1 therapy KEYTRUDA for patients with soft tissue sarcoma. This is the first chemotherapy-free trial to evaluate eftilagimod alpha in a neoadjuvant setting.

Portfolio Pulse from Charles Gross

July 28, 2023 | 11:26 am

AAPL

Apple Inc. (NASDAQ:AAPL) is tightening its privacy measures on the App Store, requiring developers to provide justifications for using certain Apple APIs that could contribute to device fingerprinting. Developers will start receiving emails from Fall 2023 if they upload an app to App Store Connect that uses a 'required reason API' without adequately describing the purpose in its privacy manifest file. By Spring 2024, App Store Connect will no longer accept apps that fail to comply with this requirement. This move is part of Apple's push towards user privacy and data protection.

Portfolio Pulse from Sudhanshu Singh

July 28, 2023 | 11:07 am

RETA

Trading of shares in Reata Pharmaceuticals has been halted pending an announcement of unspecified news.

Portfolio Pulse from Charles Gross

July 28, 2023 | 11:02 am